Cite
HARVARD Citation
Illidge, T. et al. (n.d.). Allogeneic transplant following brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma and systemic anaplastic large cell lymphoma. Leukemia & lymphoma. 56 (3), pp. 703-710. [Online].